Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival.

Författare

  • Gunnar Juliusson
  • R Billstrom
  • A Gruber
  • E Hellstrom-Lindberg
  • M Hoglund
  • K Karlsson
  • D Stockelberg
  • A Wahlin
  • M Astrom
  • C Arnesson
  • U Brunell-Abrahamsson
  • J Carstensen
  • E Fredriksson
  • E Holmberg
  • K Nordenskjold
  • F Wiklund

Summary, in English

Combination chemotherapy may induce remission from acute myeloid leukemia (AML), but validated criteria for treatment of elderly are lacking. The remission intention ( RI) rate for elderly patients, as reported to the Swedish Leukemia Registry, was known to be different when comparing the six health care regions, but the consequences of different management are unknown. The Leukemia Registry, containing 1672 AML patients diagnosed between 1997 and 2001, with 98% coverage and a median follow-up of 4 years, was completed with data from the compulsory cancer and population registries. Among 506 treated and untreated patients aged 70-79 years with AML (non-APL), there was a direct correlation between the RI rate in each health region ( range 36-76%) and the two-year overall survival, with no censored observations (6-21%) ( v 2 for trend = 11.3, P < 0.001; r(2) = 0.86, P < 0.02, nonparametric). A 1-month landmark analysis showed significantly better survival in regions with higher RI rates ( P = 0.003). Differences could not be explained by demographics, and was found in both de novo and secondary leukemias. The 5-year survival of the overall population aged 70-79 years was similar between the regions. Survival of 70-79-year-old AML patients is better in regions where more elderly patients are judged eligible for remission induction.

Publiceringsår

2006

Språk

Engelska

Sidor

42-47

Publikation/Tidskrift/Serie

Leukemia

Volym

20

Issue

1

Dokumenttyp

Artikel i tidskrift

Förlag

Nature Publishing Group

Ämne

  • Cancer and Oncology

Nyckelord

  • acute myeloid leukemia
  • elderly
  • remission induction
  • population based
  • palliation

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 1476-5551